Similar Population of CD133+ and DDX4+ VSEL-Like Stem Cells Sorted from Human Embryonic Stem Cell, Ovarian, and Ovarian Cancer Ascites Cell Cultures: The Real Embryonic Stem Cells? 2019

Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
Reproductive Division, Department of Obstetrics and Gynaecology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia. irma.virant@kclj.si.

A population of small stem cells with diameters of up to 5 μm resembling very small embryonic-like stem cells (VSELs) were sorted from human embryonic stem cell (hESC) cultures using magnetic-activated cell sorting (MACS) based on the expression of a stem-cell-related marker prominin-1 (CD133). These VSEL-like stem cells had nuclei that almost filled the whole cell volume and expressed stem-cell-related markers (CD133, SSEA-4) and markers of germinal lineage (DDX4/VASA, PRDM14). They were comparable to similar populations of small stem cells sorted from cell cultures of normal ovaries and were the predominant cells in ascites of recurrent ovarian cancer. The sorted populations of CD133+ VSEL-like stem cells were quiescent in vitro, except for ascites, and were highly activated after exposure to valproic acid and follicle-stimulating hormone (FSH), indicating a new tool to study these cells in vitro. These VSEL-like stem cells spontaneously formed clusters resembling tumour-like structures or grew into larger, oocyte-like cells and were differentiated in vitro into adipogenic, osteogenic and neural lineages after sorting. We propose the population of VSEL-like stem cells from hESC cultures as potential original embryonic stem cells, which are present in the human embryo, persist in adult human ovaries from the embryonic period of life and are involved in cancer manifestation.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000066449 Human Embryonic Stem Cells A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage. hESC,Cells, Human Embryonic Stem,Human Embryonic Stem Cell,Stem Cells, Human Embryonic,hESCs
D000071916 AC133 Antigen A member of the prominin family, AC133 Antigen is a 5-transmembrane antigen occurring as several isoforms produced by alternative splicing which are processed into mature forms. In humans, it is expressed as a subset of CD34 (bright) human hematopoietic stem cells and CD34 positive leukemias. Functionally, it is associated with roles in cell differentiation, proliferation, and apoptosis. Specifically, it regulates the organization of apical plasma membrane in epithelial cells, disk morphogenesis during early retinal development, MAPK and Akt signaling pathways, and in cholesterol metabolism. AC133-1 Antigen,AC133-2 Antigen,AC141 Antigen,CD133 Antigen,Fudenine,PROML1,Prominin,Prominin-1,Prominin-Like PROML1,AC133 1 Antigen,AC133 2 Antigen,Antigen, AC133,Antigen, AC133-1,Antigen, AC133-2,Antigen, AC141,Antigen, CD133,Prominin 1,Prominin Like PROML1

Related Publications

Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
October 2019, Stem cell reviews and reports,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
May 2014, Biochemical and biophysical research communications,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
September 2019, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
September 2020, International journal of molecular sciences,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
January 2008, Cell and tissue research,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
January 2008, Stem cell reviews,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
January 2010, Biotechnology progress,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
January 2021, iScience,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
December 2010, Cancer biology & therapy,
Irma Virant-Klun, and Petra Skerl, and Srdjan Novakovic, and Eda Vrtacnik-Bokal, and Spela Smrkolj
June 2016, Scientific reports,
Copied contents to your clipboard!